Document is current
Any future updates will be listed below
-
Authors
Fernández-Tajes, Juan
Gaulton, Kyle J.
van de Bunt, Martijn
Torres, Jason
Thurner, Matthias
Mahajan, Anubha
Gloyn, Anna L.
Lage, Kasper
McCarthy, Mark I.
-
Funding
Funding for this research was provided by:
Wellcome Trust (095101)
Wellcome Trust (090532)
Wellcome Trust (200837)
Wellcome Trust (203141)
Wellcome Trust (098381)
Wellcome Trust (106130)
Wellcome Trust (090367)
National Institutes of Health (U01DK105535)
National Institutes of Health (R01MH090941)
National Institutes of Health (R01DK098032)
National Institutes of Health (U01DK085545)
National Institutes of Health (R01MH101814)
Medical Research Council (G0601261)
Medical Research Council (MR/L020149/1)
Horizon 2020 (667191)
Novo Nordisk Fonden (NNF15CC0018486)
- License Information
-
More Information
Article History
Received: 6 October 2018
Accepted: 8 March 2019
First Online: 26 March 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: MIM serves on advisory panels for Pfizer, NovoNordisk, Zoe Global; has received honoraria from Pfizer, NovoNordisk, Sanofi-Aventis and Eli Lilly; has stock options in Zoe Global and has received research funding from Abbvie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Pfizer, Roche, Sanofi-Aventis, Servier, Takeda. We would like to clarify that Novo Nordisk Foundation in organisational terms is responsible for awarding grants and Novo Holdings A/S manages the Foundation’s commercial activities.The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
